Vice President and Global Head of Logistics and Supply Chain Excellence
Dr. Reddy’s Laboratories Ltd.
Dr Ravi Prakash Mathur is a supply chain professional and a published author with more than 25 years of experience.
He has a strong focus on of supply chain and digital transformation, integrated business planning, global logistics, and projects based on emerging digital technologies. He is a member of Supply Chain Councils and on Academic Boards of Business Schools and regularly speaks at international conferences and top-ranked universities in India.
In 2020, he coauthored an academic paper, titled “Dr Reddy's Laboratories Ltd: Inventory Management Under Resource Constraints” hosted by Harvard Business Publishing Education and is also available on the HBR store.
He was amongst the “Top 25 Digitalist Thought Leaders of India” announced by SAP Ace awards in 2015. In 2014 he co-authored the book “Quality Assurance in Pharmaceuticals & Operations Management and Industrial Safety”.
In this webinar, Dr. Ravi Prakash Mathur, Vice President and Global Head of Logistics and Supply Chain Excellence, Dr. Reddy's Laboratories Ltd, addresses - the API supply chain challenges and supply chain management in the pharmaceutical industry complemented with live case studies on how to predict the impact of supply disruptions and achieve sustainability targets.
The first section of the webinar provides insights on sustainability pharmaceutical supply chain focusing on reducing the carbon footprint in the supply chains and logistics and Dr. Reddy's journey in sustainability so far, covering aspects of product responsibility, transparency, operational excellence, and human dignity, equal opportunity, and community development.
The following section covers - managing COVID-19 induced disruptions and business continuity planning and interventions in response to the pandemic and supply chain management in pharmaceutical industry. The role of collaboration in managing disruptions – Strong partner network, cross-industry collaboration groups and opening to new possibilities, leveraging data for LDM & reviewing operations, slicing, and dicing of data for identifying levers for LDM and third-party risk management for sourcing.
The next section of the webinar gives information on digital transformation, integrated business planning (IBP) - project O2: one team, one plan vision, and key objectives, IBP platform features, framework, cross-functional processes, and change management steps. The final session covers – global supply chain intelligence, predicting the impact of disruptions, market intelligence, and critical benefits of procurement dashboards.
Pharmaceutical supply chain management have become complex and become prone to disruptions. As a result, there is a need to keep an eye on and be aware of emerging external scenarios and assess their impact on customer product availability. Supply uncertainty also impacts organizational performance and must synchronize the business processes to create visibility of various performance indicators in advance.
Are you interested in learning more about our global supply chain intelligence, pharmaceutical supply chain, integrated business plan, carbon footprint, managing COVID-19 induced disruptions, and robust business continuity plans? Then contact us at api@drreddys.com
No information in this catalog - including any reference to any product or service - constitutes an offer for sale, or be construed as representing an offer for sale. Products protected under valid patents are not offered or supplied for commercial use. However, the research quantities of such products may be offered for the purpose of regulatory submissions, wherever such regulatory exemptions exist. The buyers should make their independent evaluation of the patent scenario for their respective markets and will be responsible for all patent related liabilities. Products protected under valid patents in India are not available for commercial use but would be available for Section 107A purposes.